Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
698 articles · Health Tech & Medtech
On Wednesday, Berlin-based Nelly, a health and fintech company, announced that it has raised €50M in a Series B funding round co-led by Cathay Innovation and Notion Capital.
Paris-based Robeauté, a medtech startup focused on neurosurgical microrobots, has raised $28M (approximately €27.28M) in funding led by Plural, Cherry Ventures, and Kindred Ventures.
Horw, Switzerland-based CeQur, a medical device company dedicated to simplifying mealtime insulin delivery for individuals, announced that it has secured $120M (approximately €116.4M) in the financing round.
Oxford Cancer Analytics (OXcan), a UK-based medtech company that develops blood tests for early cancer detection using proteomics and AI…
Amsterdam-based Leyden Labs, a platform working to free people from the threat of respiratory viruses, announced Thursday that it has raised $70M (approximately €68M) in funding.
Amsterdam-based uniQure, a biotechnology company specialising in human gene-based therapies, recently announced its public offering of 4,411,764 ordinary shares at $17.00 per share.
On Thursday, London-based Verdiva Bio Limited, a clinical-stage biopharmaceutical company, announced its launch to focus on developing innovative therapies for obesity and other cardiometabolic disorders.
On Friday, Leuven, Belgium-based Capricorn Partners, announced the first close of its Capricorn Health-tech Fund II at €51M to support innovative health technology startups.
On Tuesday, Dublin-based FIRE1, a connected medical device solutions company, announced that it has secured $120M (approximately €115M) in financing led by Polaris Partners and Elevage Medical Technologies.
Copenhagen-based Orbis Medicines, a drug discovery company, has raised €90M in a Series A funding round, bringing its total funding to…
Oulu, Finland-based Oura, a company behind Oura Ring, on Thursday announced that it has secured $200M (approximately €192M) in Series D…
Oss, The Netherlands-based Citryll, a biotech company, announced on Monday that it has closed an oversubscribed €85M in a Series B funding round.
